File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: The potential role of early-phase graft injury in induction of late-phase chemoresistance after liver transplantation

TitleThe potential role of early-phase graft injury in induction of late-phase chemoresistance after liver transplantation
Authors
Issue Date2010
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jtoc/106570021
Citation
The 16th Annual International Congress of the Liver Transplantation Society (ILTS 2010), Hong Kong, 16-19 June 2010. In Liver Transplantation, 2010, v. 16 suppl. S1, p. S141, abstract no. P-75 How to Cite?
AbstractOBJECTIVE: We aim to investigate the potential role of acute phase liver graft injury on induction of late phase chemoresistance after liver transplantation and to explore the underlying mechanism. MATERIALS AND METHODS: A rat orthotopic liver transplantation model using cirrhotic recipients was established with applying whole or small-for-size (50%) graft. The recipients were injected with a rat hepatoma cell line (MH7777) via portal vein after reperfusion. Proline tyrosine kinase (Pyk2) expression was compared between small-for-size and whole grafts, as well as the tumor developed from small and whole grafts. Pyk2-overexpressed HCC cell stable clones were established. The role of Pyk2 in cisplatin resistance was investigated by in vitro studies on HCC cell proliferation and apoptosis under cisplatin environment, and further confirmed by in vivo xenograft tumorigenesis and orthotopic nude mice models. The gene profile of Pyk2-overexpressed HCC cells was screened by cDNA microarray to explore the mechanism. RESULTS: Intragraft gene expression of Pyk2 increased gradually after transplantation (4h, 2d, 4d and 7d) in both small-for-size and whole grafts. mRNA levels of Pyk2 were significantly higher in small-for-size grafts at day 4 (55.71 vs 24.25 folds of normal liver, p=0.005) and day 7 (90.51 vs 48.5 folds, p=0.005) after transplantation. Pyk2 expression level was also significantly higher in liver tumor from small-for-size graft at day 14 (1.75 folds of whole graft, p=0.01) and day 21 (2.41 folds of whole graft, p=0.01) after operation. In vitro studies including MTT, colony formation and Annexin-V-FLOUS assay showed that overexpression of Pyk2 promoted cell proliferation and increased survival rate under cisplatin treatment. cDNA microarray screening showed that MDR1, GAGE, STAT1, CASP9 and MAP7, which related to drug resistance, were up-regulated in Pyk2-overexpressed HCC cells. The in vivo study demonstrated that suppression of Pyk2 could sensitize liver tumor to cisplatin by induction of significant necrosis and apoptosis. CONCLUSION: Pyk2 was significantly up-regulated in both of small-for-size grafts and the tumor developed from small graft after transplantation. Pyk2 overexpression in HCC cells remarkably induced cisplatin resistance. Therefore, earlyphase liver graft injury may induce late-phase chemoresistance after liver transplantation by up-regulating Pyk2.
DescriptionYoung Investigator Award - Poster Session 1: abstract no. P-75
This journal supplement entitled: The International Liver Transplantation Society: 16th Annual International Congress
Persistent Identifierhttp://hdl.handle.net/10722/126955
ISSN
2015 Impact Factor: 3.951
2015 SCImago Journal Rankings: 1.763

 

DC FieldValueLanguage
dc.contributor.authorGeng, Wen_HK
dc.contributor.authorMan, Ken_HK
dc.contributor.authorCheng, Qen_HK
dc.contributor.authorNg, KTPen_HK
dc.contributor.authorLiu, XBen_HK
dc.contributor.authorLiu, Yen_HK
dc.contributor.authorPoon, RTPen_HK
dc.contributor.authorFan, STen_HK
dc.contributor.authorLo, CMen_HK
dc.date.accessioned2010-10-31T12:58:08Z-
dc.date.available2010-10-31T12:58:08Z-
dc.date.issued2010en_HK
dc.identifier.citationThe 16th Annual International Congress of the Liver Transplantation Society (ILTS 2010), Hong Kong, 16-19 June 2010. In Liver Transplantation, 2010, v. 16 suppl. S1, p. S141, abstract no. P-75en_HK
dc.identifier.issn1527-6465-
dc.identifier.urihttp://hdl.handle.net/10722/126955-
dc.descriptionYoung Investigator Award - Poster Session 1: abstract no. P-75-
dc.descriptionThis journal supplement entitled: The International Liver Transplantation Society: 16th Annual International Congress-
dc.description.abstractOBJECTIVE: We aim to investigate the potential role of acute phase liver graft injury on induction of late phase chemoresistance after liver transplantation and to explore the underlying mechanism. MATERIALS AND METHODS: A rat orthotopic liver transplantation model using cirrhotic recipients was established with applying whole or small-for-size (50%) graft. The recipients were injected with a rat hepatoma cell line (MH7777) via portal vein after reperfusion. Proline tyrosine kinase (Pyk2) expression was compared between small-for-size and whole grafts, as well as the tumor developed from small and whole grafts. Pyk2-overexpressed HCC cell stable clones were established. The role of Pyk2 in cisplatin resistance was investigated by in vitro studies on HCC cell proliferation and apoptosis under cisplatin environment, and further confirmed by in vivo xenograft tumorigenesis and orthotopic nude mice models. The gene profile of Pyk2-overexpressed HCC cells was screened by cDNA microarray to explore the mechanism. RESULTS: Intragraft gene expression of Pyk2 increased gradually after transplantation (4h, 2d, 4d and 7d) in both small-for-size and whole grafts. mRNA levels of Pyk2 were significantly higher in small-for-size grafts at day 4 (55.71 vs 24.25 folds of normal liver, p=0.005) and day 7 (90.51 vs 48.5 folds, p=0.005) after transplantation. Pyk2 expression level was also significantly higher in liver tumor from small-for-size graft at day 14 (1.75 folds of whole graft, p=0.01) and day 21 (2.41 folds of whole graft, p=0.01) after operation. In vitro studies including MTT, colony formation and Annexin-V-FLOUS assay showed that overexpression of Pyk2 promoted cell proliferation and increased survival rate under cisplatin treatment. cDNA microarray screening showed that MDR1, GAGE, STAT1, CASP9 and MAP7, which related to drug resistance, were up-regulated in Pyk2-overexpressed HCC cells. The in vivo study demonstrated that suppression of Pyk2 could sensitize liver tumor to cisplatin by induction of significant necrosis and apoptosis. CONCLUSION: Pyk2 was significantly up-regulated in both of small-for-size grafts and the tumor developed from small graft after transplantation. Pyk2 overexpression in HCC cells remarkably induced cisplatin resistance. Therefore, earlyphase liver graft injury may induce late-phase chemoresistance after liver transplantation by up-regulating Pyk2.-
dc.languageengen_HK
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jtoc/106570021-
dc.relation.ispartofLiver Transplantation-
dc.rightsLiver Transplantation. Copyright © John Wiley & Sons, Inc.-
dc.titleThe potential role of early-phase graft injury in induction of late-phase chemoresistance after liver transplantationen_HK
dc.typeConference_Paperen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0041-1337&volume=90&spage=269&epage=&date=2010&atitle=The+potential+role+of+early-phase+graft+injury+in+induction+of+late-phase+chemoresistance+after+liver+transplantation-
dc.identifier.emailGeng, W: gengwei1999@hotmail.comen_HK
dc.identifier.emailMan, K: kwanman@hkucc.hku.hken_HK
dc.identifier.emailCheng, Q: qiaocheng@hotmail.comen_HK
dc.identifier.emailNg, KTP: ledodes@hku.hken_HK
dc.identifier.emailLiu, XB: liuxb301@hku.hken_HK
dc.identifier.emailLiu, Y: liu0607yan@hkusua.hku.hken_HK
dc.identifier.emailPoon, RTP: poontp@hkucc.hku.hken_HK
dc.identifier.emailFan, ST: stfan@hku.hk-
dc.identifier.emailLo, CM: chungmlo@hkucc.hku.hk-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1002/lt.22086-
dc.identifier.hkuros174397en_HK
dc.identifier.volume16-
dc.identifier.issuesuppl. S1-
dc.identifier.spageS141, abstract no. P-75-
dc.identifier.epageS141, abstract no. P-75-
dc.publisher.placeUnited States-
dc.description.otherThe 16th Annual International Congress of the Liver Transplantation Society, Hong Kong, 16-19 June 2010. In Liver Transplantation, 2010, v. 16 suppl. S1, p. S141, abstract no. P-75-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats